$17.64
7/31/19
The Calamos Timpani Active SMID Growth ETF (CTAG) invests in small- and mid-cap companies identified through Timpani's fundamental momentum process, which targets companies with fast, sustainable growth and improving earnings expectations.
Complement large-cap exposure. Adds actively managed small and mid-cap growth exposure beyond the market's largest names.
Pursue long-term growth. Seeks companies with durable growth potential before the market fully recognizes their potential.
Access the strategy through an ETF. Offers the trading flexibility and structural features of an ETF.
| Name | 1 Year | 3 Year | 5 Year | Since Inception (07/31/19) |
|---|---|---|---|---|
| CTAG NAV | 54.47 | 32.20 | 10.74 | 15.93 |
| Russell 2500 Growth Index | 32.94 | 16.40 | 4.98 | 10.81 |
| Name | 1 Year | 3 Year | 5 Year | Since Inception (07/31/19) |
|---|---|---|---|---|
| CTAG NAV | 26.40 | 26.79 | 7.21 | 13.38 |
| Russell 2500 Growth Index | 15.32 | 14.13 | 3.51 | 9.49 |
On September 21, 2026, Calamos Timpani Active SMID Growth ETF (the "Fund") acquired the assets and assumed the liabilities of the Calamos Timpani SMID Growth Fund (the "Predecessor Fund") in a reorganization (the "Reorganization"). As a result of the Reorganization, performance prior to the Fund's inception date reflects actual performance and expenses of the Class I shares of the Predecessor Fund, without any adjustments. The Fund has the same investment objective and substantially similar strategies as the Predecessor Fund. However, the Fund has a lower net expense ratio than each share class of the Predecessor Fund. As a result, the performance returns of the Fund for the periods shown would have been different than those of the Predecessor Fund. Had the Predecessor Fund been structured as an ETF, its performance may have differed. You can obtain current performance data by visiting www.Calamos.com.
The Fund's (and Predecessor Fund's) past performance (before and after taxes) is not necessarily an indication of how the Fund will perform in the future.
Performance data quoted represents past performance, which is no guarantee of future results. Current performance may be lower or higher than the performance quoted. The principal value of an investment will fluctuate so that your shares, when sold, may be worth more or less than their original cost. Returns at NAV reflect the deduction of the Fund's management fee and other expenses, which can be found on the fund fees and expenses tab. You can purchase or sell common shares daily. Like any other stock, market price will fluctuate with the market. Upon sale, your shares may have a market price that is above or below net asset value and may be worth more or less than your original investment.
The Russell 2500® Growth Index measures the performance of the small to midcap growth segment of the US equity universe. It includes those Russell 2500 companies with higher growth earning potential. The Russell 2500 Growth Index is published and maintained by FTSE Russell.
Unmanaged index returns, unlike fund returns, do not reflect fees, expenses or sales charges. Investors cannot invest directly in an index.
Average annual total return measures net investment income and capital gain or loss from portfolio investments as an annualized average. All performance shown assumes reinvestment of dividends and capital gains distributions.
The fund's expense ratio as of the prospectus dated 9/18/2026 is 0.79%.
| Sector | % of Assets | Russell 2500 Growth Index |
|---|---|---|
| Information Technology | 34.8% | 23.8% |
| Industrials | 29.3% | 21.6% |
| Health Care | 15.7% | 24.5% |
| Consumer Discretionary | 10.0% | 9.6% |
| Financials | 8.4% | 7.7% |
| Consumer Staples | 1.6% | 1.4% |
| Energy | 0.5% | 3.3% |
| Materials | 0.0% | 3.1% |
| Communication Services | 0.0% | 2.6% |
| Real Estate | 0.0% | 1.6% |
| Utilities | 0.0% | 0.6% |
| Other | 0.0% | 0.0% |
| Market CAP Range | % of Assets |
|---|---|
| <=$2bil | 2.2% |
| >$2bil<=$4bil | 7.4% |
| >$4bil<=$7bil | 19.4% |
| >$7bil<=$16bil | 25.9% |
| >$16bil | 45.0% |
| Name | Fund | Russell 2500 Growth Index |
|---|---|---|
| Number of Holdings | 88 | 1,261 |
| Debt/Capital | 37.3% | 44.4% |
| ROIC | 24.3% | 15.1% |
| 1yr Forward EPS Growth | 102.5% | 31.5% |
| PEG Ratio | 1.3x | 1.4x |
A list of all fund holdings is made available daily through the link below.
| Holding | % |
|---|---|
| Lumentum Holdings, Inc. | 5.6% |
| Dave, Inc. | 4.7% |
| Guardant Health, Inc. | 3.7% |
| Marex Group, Ltd. | 3.0% |
| SiTime Corp. | 2.8% |
| Silicon Motion Technology Corp. (ADR) | 2.7% |
| Rush Street Interactive, Inc. | 2.4% |
| Xometry, Inc. | 2.3% |
| Travere Therapeutics, Inc. | 2.2% |
| Ligand Pharmaceuticals, Inc. | 2.0% |
| Name | Frequency |
|---|---|
| Distributions | ANNUAL |
| Capital Gains | ANNUAL |
| Detail | Value |
|---|---|
| Ticker | CTAG |
| Inception Date | 7/31/19 |
| Expense | % |
|---|---|
| Management Fees | 0.79% |
| Acquired Fund Fees and Expenses | N/A |
| Total Expense Ratio | 0.79% |
| Name | Fund |
|---|---|
| Inception Date | 7/31/19 |
| Ticker Symbol | CTAG |
| CUSIP number | 12811T480 |
This summary contains important information about the investment objective, fees and expenses, principal investment strategies, principal risks and performance.
You should read the accompanying prospectus and any accompanying prospectus supplement, which contain important information, before deciding whether to invest in our securities.
The statement of additional information is a supplementary document to the fund’s prospectus and contains additional information about the fund and includes further disclosure regarding its operations.
